We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of LUMO yet.

LUMO Hedge Fund Activity: Q4 2024 in Review

0 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2024, worth a combined $0 — down 100% from $8.08M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of LUMO and 0 opened new positions — a net loss of 28 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Private Advisor Group, exiting entirely with an estimated $2.88M sold.

  • 0 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2024, down from 28 in Q3 2024.
  • Funds reported $0 of Lumos Pharma, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2024 and 28 closed out, a net change of -28 holders.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2024 was Private Advisor Group, an estimated $2.88M sold.

Based on aggregated 13F filings for Q4 2024.